4 studies found for:    20525992 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Ipilimumab and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Melanoma With Brain Metastases
Conditions: Recurrent Melanoma;   Stage IV Melanoma;   Tumors Metastatic to Brain
Interventions: Drug: Ipilimumab;   Radiation: Whole-Brain Radiation Therapy (WBRT);   Radiation: Stereotactic Radiosurgery (SRS)
2 Unknown  A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
Condition: Metastatic Malignant Melanoma
Intervention: Drug: Ipilimumab and Fotemustine
3 Active, not recruiting Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Condition: Malignant Melanoma, Metastatic
Interventions: Biological: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF);   Biological: Ipilimumab
4 Completed
Has Results
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
Conditions: Melanoma;   Metastases
Interventions: Drug: MDX-010 (anti-CTLA4) monoclonal antibody;   Biological: MDX-1379 (gp100) Melanoma Peptide Vaccine

Indicates status has not been verified in more than two years